Vigil Neuroscience, Inc. announced a private placement of 537,634 Series A non-voting convertible preferred shares at a price of $7.44 per share for the gross proceeds of $3,999,996.96 on June 27, 2024. The transaction included participation from new investor, Sanofi Pasteur Biologics, LLC. Each share shall be convertible into ten shares of common stock.